28th Jun, 2017
Language Selection
Email
Zoosnet
Who we are
Why choose Fuda
Treatment guide
For your health
Fuda news
:
Cancer is a systemic disease with tumors as a local manifestation of the disease. Once cancer occurs in a person, cancerous cells will be found in the body. Surgical removal of tumors in no way implies that one is cured of cancer. For example, breast cancer can relapse even if the original tumors were removed.Like hypertension and diabetes, cancer is a chronic disease. The disease may take a few years to manifest itself - from its occurrence until the emergence of tumors. In some cases, cancer cells may exist in a stage of ....
:
:
:
:
Prof. Li Haibo,M.D._our doctors_why choose fuda_Fuda Cancer Hospital Guangzhou_Cancer Treatment China_Tumor Technology_广州复大肿瘤医院_癌症治疗_微创治疗_癌症疗法
Prof. Li Haibo,M.D.
Size: S / L
Previous
2010/5/27

 


 

Vice President of Fuda Cancer Hospital,

Specialist in Cardiothoracic Surgery

 

Dr Li Haibo graduated from Shandong Medical University in 1994 with a medical degree. He had been working in the field of Cardiothoracic Surgery after graduation and obtained his PhD from First Military Medical University in Guangzhou in 2006.

Dr Li was recruited to Fuda Cancer Hospital in 2008, serving as Director of Cardiothoracic Surgery department, and was promoted to vice president of Fuda Cancer Hospital in December 2011.  His speciality has been focusing on surgical treatment of lung cancer , esophageal cancer and cryosurgery in combination with iodine seed implantation therapy for advanced lung and esophageal cancers. Dr Li has so far successfully treated more than 300 cancer patients. Dr Li contributed the chapter "Percutaneous Cryoablation for Treatment of Painful Bone Metastases" for the book MODERN CRYOSURGERY FOR CANCER published by World scientific Publishing in 2012.


 

Academic papers

 

1、Jibing Chen, Bing Liang, Yuanying Yuan, Chunyan Liu,Li Li, Haibo Li,Feng Mu, Jiansheng Zuo, Kecheng Xu. Comprehensive treatment of malignant mesothelioma patients after the failure of systemic chemotherapy. Cryobiology. 2012 Dec;65(3):2848.
 
2、Lizhi Niu, Lihua He, Liang Zhou, Feng Mu, Binghui Wu, Haibo Li, Zhenzhong Yang, Jiansheng Zuo, Kecheng Xu. Percutaneous Ultrasonography and Computed Tomography Guided Pancreatic Cryoablation: Feasibility and Safety Assessment. Cryobiology. 2012,65:301307.
 
3、Feng Mu, Lizhi Niu, Haibo Li , Mengtian Liao, Li Li, Chunyan Liu, Jibing Chen, Jialiang Li, Jiansheng Zuo, Kecheng Xu. Percutaneous comprehensive cryoablation for metastatic hepatocellular cancer. Cryobiology. 2012 Dec 10.[Epub ahead of print]
 
4、Lizhi Niu, Liang Zhou, Nikolai N. Korpan, Binghui Wu, Jun Tang, Feng Mu, Haibo Li, Zhuofang Hao, David Chiu, Kecheng Xu. Experimental study on pulmonary cryoablation in a porcine model of normal lungs. Technol Cancer Res Treat. 2012 Aug;11(4):38994.
 
5、David Chiu, Lizhi Niu, Feng Mu, Xiang Peng, Liang Zhou, Haibo Li, Rongrong Li, Jiazhang Ni,Ningzi Jiang, Yize,Zuofang Hao, Kecheng Xu. The experimental study for efficacy and safety of pancreatic cryosurgery. Cryobiology. 2010,60:281-286.
 
 
 
Who we are
Why choose Fuda
Treatment guide
For your health
版权所有 Copyright (c) 2013 by fudahospital.com. All Rights Reserved.
· 粤ICP备13048536号 · 工信部网址 · 安全检测 ·